NDC 0032-2636 – Creon

Pancrelipase Lipase 24000 [USP'U]/1; Pancrelipase Protease 76000 [USP'U]/1; Pancrelipase Amylase 120000 [USP'U]/1 · Capsule, Delayed Release Pellets · Oral

Human Prescription Drug 2 recalls

Product NDC0032-2636

Product details

Brand name
Creon
Generic name
Pancrelipase
Labeler
AbbVie Inc.
Dosage form
Capsule, Delayed Release Pellets
Route
Oral
Marketing category
BLA · BLA020725
Marketed since
October 12, 2023
Listing expires
December 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for Creon →

Package NDC codes (3)

Package NDCDescriptionSince
0032-2636-01100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0032-2636-01)Oct 12, 2023
0032-2636-30 sample24 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0032-2636-30)Oct 12, 2023
0032-2636-70240 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0032-2636-70)Oct 12, 2023

Recalls mentioning this NDC

Other Creon products